The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; none of the 32 sources its claims cite is checked for support yet.
YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs
Open accessAbstract
N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic messenger RNA (mRNA) and plays critical roles in RNA biology. The function of this modification is mediated by m6A-selective ‘reader’ proteins of the YTH family, which incorporate m6A-modified mRNAs into pathways of RNA metabolism. Here, we show that the m6A-binding protein YTHDC1 mediates export of methylated mRNA from the nucleus to the cytoplasm in HeLa cells. Knockdown of YTHDC1 results in an extended residence time for nuclear m6A-containing mRNA, with an accumulation of transcripts in the nucleus and accompanying depletion within the cytoplasm. YTHDC1 interacts with the splicing factor and nuclear export adaptor protein SRSF3, and facilitates RNA binding to both SRSF3 and NXF1. This role for YTHDC1 expands the potential utility of chemical modification of mRNA, and supports an emerging paradigm of m6A as a distinct biochemical entity for selective processing and metabolism of mammalian mRNAs.
Overview
CoChat Summary
TL;DR
YTHDC1, a nuclear m6A reader, mediates nuclear-to-cytoplasmic export of methylated mRNAs in HeLa cells by linking m6A recognition to the export adaptor SRSF3 and the export receptor NXF1. Knockdown of YTHDC1 causes nuclear accumulation and cytoplasmic depletion of its target transcripts, independent of pre-mRNA splicing.
Key findings
- Knockdown of YTHDC1 increased nuclear m6A levels and extended the apparent half-life of nuclear mRNA methylation more than 2-fold after transcription inhibition; YTHDF2 knockdown extended cytoplasmic m6A apparent half-life by ~4-fold.
- YTHDC1 knockdown did not change total mRNA m6A/A but caused nuclear accumulation and cytoplasmic depletion of m6A and polyA RNA; overexpression of YTHDC1 after YTHDF2 knockdown increased cytoplasmic m6A.
- YTHDC1 targets were defined as transcripts bound in PAR-CLIP and enriched at least 2-fold in RIP-seq, yielding over 700 targets; upon YTHDC1 knockdown, target abundance increased in nuclear RNA and decreased in cytoplasmic RNA, while total target abundance was unchanged.
- YTHDC1 interacts with SRSF3, and SRSF3 interacts with NXF1; YTHDC1 knockdown reduced m6A enrichment by SRSF3 and abolished m6A enrichment by NXF1. Only transcripts bound by both YTHDC1 and SRSF3 showed significant nuclear accumulation upon YTHDC1 knockdown.
- YTHDC1 knockdown affected alternative splicing, with 426 events at Δpsi ≥0.2; 85/737 (11.5%) occurred in YTHDC1 targets versus 108/4,848 (2.2%) in non-targets, but reporter assays showed export effects independent of splicing and m6A binding.
Methods
- HeLa cells were used for siRNA knockdown, plasmid transfection, cellular fractionation, and RNA isolation; m6A/A was quantified by LC-MS/MS on polyA-selected, ribosomal RNA-depleted mRNA from total, nuclear, and cytoplasmic fractions.
- RNA substrates were identified by YTHDC1 PAR-CLIP and RIP-seq, subcellular transcriptomes by RNA-seq after YTHDC1 knockdown, and binding by SRSF3/NXF1 by CLIP or RIP followed by LC-MS/MS and sequencing.
- Mechanistic tests included endogenous and FLAG immunoprecipitation, western blotting, polyA FISH, nascent RNA labeling with 5-ethynyl uridine, RT-qPCR, and a Tet-inducible BoxB-luciferase reporter tethering assay with full-length, N-terminal, C-terminal, and W377A YTHDC1 constructs.
Limitations
- The paper does not include a dedicated limitations section.
- Evident from the text: most experiments are in HeLa cells, so generality to other cell types or organisms is not established.
- The m6A/A measurements are ensemble bulk measurements; the paper notes this allows relative clearance comparisons without determining absolute half-lives of individual mRNAs.
- Export conclusions rely heavily on knockdown/overexpression and tethering assays; the reporter system is splicing-independent and methylation-independent due to BoxB–lambda peptide binding, which the authors present as an advantage but which also means it does not test endogenous m6A-dependent export directly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



















Verification
Claims the paper makes
0 Valid · 0 Not valid · 19 Not checked · 124 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Upon knockdown of YTHDC1, we observed nuclear accumulation of nascent mRNA for both APC and MCL1 transcripts compared to control, whereas the difference in nuclear SOX12 mRNA abundance was modest and not significant in our assay (Figure 4A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 mediates nuclear export of nascent mRNA
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We show that upon knockdown of YTHDC1, mature mRNA localization is perturbed independently of a splicing requirement or splicing outcomes.”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Discussion > m6A selectivity in nuclear mRNA processing and export
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We observed enrichment of m6A in mRNA bound by SRSF3 under both conditions.”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 facilitates RNA binding to SRSF3 and NXF1
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although YTHDC1 interacts with SRSF3, we did not observe any direct interaction between YTHDC1 and the export receptor NXF1, nor did we observe interaction between YTHDC1 and the common mRNA adaptor protein ALYREF (Figure 5A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 bridges m6A selectivity to mRNA export via SRSF3
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knockdown of YTHDC1 does not affect the m6A/A ratio in mRNA transcripts from whole cell lysate, but results in accumulation of m6A in nuclear mRNA and in an accompanying cytoplasmic depletion of m6A levels (Figure 2A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 mediates nuclear to cytoplasmic transport of methylated mRNAs
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
82 more claims
Create a free account to see all 143 claims and to verify the 17 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 35
- The quote only partly states this claim. 1
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,167
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
N6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558 · cited 5×
“Firefly luciferase was fused to five copies of the BoxB sequence and placed under control of a Tet-off promoter (Wang et al., 2014a).”
BackgroundMethodInfluentialSelf-citationALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550
Self-citation
Cited by
Items 401–500 of 1,260
Shaping the landscape of N6 -methyladenosine RNA methylation in Arabidopsis
Wong, C. E., Zhang, S., Xu, T., Zhang, Y., Teo, Z. W. N., Yan, A., Shen, L., & Yu, H. Q. (2023) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiad010 · Cited by 36
Role of m6A modification in dysregulation of Wnt/β-catenin pathway in cancer
Tabnak, P., Ghasemi, Y., Natami, M., Khorram, R., & Ebrahimnezhad, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114023 · Cited by 35
Kim, Y., Saville, L., O’Neill, K., Garant, J., Liu, Y., Haile, S., Ghashghaei, M., Hoang, Q. A., Louwagie, A., Park, Y., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100872 · Cited by 35
Epitranscriptomics: A New Regulatory Mechanism of Brain Development and Function
Noack, F., & Calegari, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00085 · Cited by 35
CircRNAs open a new era in the study of cardiovascular disease (Review)
Yu, Z., Huang, Q., Zhang, Q., Wu, H., & Zhong, Z. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4792 · Cited by 35
Xu, J., Liu, Y., Liu, J., Xu, T., Cheng, G., Shou, Y., Tong, J., Liu, L., Zhou, L., Xiao, W., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.602485 · Cited by 35
Yao, L., Yin, H., Hong, M., Wang, Y., Yu, T., Teng, Y., Li, T., & Wu, Q. (2021) · Leukemia · doi:10.1038/s41375-021-01225-1 · Cited by 35
Zhang, Z., Zhang, C., Luo, Y., Zhang, G., Wu, P., Sun, N., & He, J. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.525 · Cited by 35
Self-citationDepletion of m6A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin
Gao, S., Sun, H., Chen, K., Gu, X., Chen, H., Jiang, L., Chen, L., Zhang, S., Liu, Y., Shi, D., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16955 · Cited by 35
Self-citationCao, D., Ge, S., & Li, M. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100412 · Cited by 35
In situ visualization of m6A sites in cellular mRNAs
Sheehan, C. J., Marayati, B. F., Bhatia, J., & Meyer, K. D. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad787 · Cited by 35
Roles and implications of mRNA N 6 ‐methyladenosine in cancer
Zeng, L., Huang, X., Zhang, J., Lin, D., & Zheng, J. (2023) · 癌症:英文版 · doi:10.1002/cac2.12458 · Cited by 34
Self-citationRole of identified RNA N6-methyladenosine methylation in liver
Xu, K., Sun, Y., Sheng, B., Yiwen, Z., Wu, X., & Xu, K. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.05.005 · Cited by 34
Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology
Chen, J., Tian, Y., Zhang, Q., Ren, D., Zhang, Q., Xiao, Y., Wang, L., He, Z., Zhang, W., Zhang, T., et al. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0157 · Cited by 34
Sokpor, G., Xie, Y., Nguyen, H. P., & Tuoc, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.656849 · Cited by 34
RNA regulatory mechanisms that control antiviral innate immunity
Gokhale, N. S., Smith, J. R., Gelder, R. D. V., & Savan, R. (2021) · Immunological Reviews · doi:10.1111/imr.13019 · Cited by 34
m6A in the Signal Transduction Network
Jang, K.-H., Heras, C. R., & Lee, G. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.0017 · Cited by 34
Jia, J., Wu, S., Jia, Z., Wang, C., Ju, C., Sheng, J., He, F., Zhou, M., & He, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73093 · Cited by 34
Lu, B., Chen, X., Liu, X., Chen, J., Qin, H., Chen, S., & Zhao, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03802-z · Cited by 34
Xing, K., Liu, Z., Liu, L., Zhang, J., Qanmber, G., Wang, Y., Liu, L., Gu, Y., Zhang, C., Li, S., et al. (2023) · The Plant Journal · doi:10.1111/tpj.16274 · Cited by 33
RNA m6A modification facilitates DNA methylation during maize kernel development
Luo, J. L., Guo, T., Wang, M., Liu, J., Zheng, L.-M., & He, Y. (2023) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiad625 · Cited by 33
Ramifications of m6A Modification on ncRNAs in Cancer
Mehmood, R. (2024) · Current Genomics · doi:10.2174/0113892029296712240405053201 · Cited by 33
Roberts, J. T., Porman, A. M., & Johnson, A. M. (2020) · RNA · doi:10.1261/rna.078543.120 · Cited by 33
Xu, S., Xu, X., Zhang, Z., Yan, L., Zhang, L., & Du, L. (2021) · Respiratory Research · doi:10.1186/s12931-021-01728-6 · Cited by 33
Self-citationEpigenetic regulation of N6‐methyladenosine modifications in obesity
Sun, M., & Zhang, X. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13571 · Cited by 33
The m6A-epitranscriptome in brain plasticity, learning and memory
Widagdo, J., Wong, J. J. L., & Anggono, V. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.023 · Cited by 33
RNA Methylation in Systemic Lupus Erythematosus
Lv, X., Liu, X., Zhao, M., Wu, H., Zhang, W., Lu, Q., & Chen, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696559 · Cited by 33
The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis
Fu, J., Cui, X., Zhang, X., Cheng, M., Li, X., Guo, Z., & Cui, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.733871 · Cited by 33
Extracellular RNA: mechanisms of secretion and potential functions
Borniego, L., & Innes, R. W. (2023) · Journal of Experimental Botany · doi:10.1093/jxb/erac512 · Cited by 33
Wu, Y., Jin, M., Fernandez, M. M., Hart, K. L., Liao, A., Ge, X., Fernandes, S. M., McDonald, T., Chen, Z., Röth, D., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0156 · Cited by 33
Oncogenic SRSF3 in health and diseases
Jia, R., & Zheng, Z. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83368 · Cited by 32
Chen, S., Chen, Y., Yu, L., & Hu, X. (2023) · Molecular & Cellular Toxicology · doi:10.1007/s13273-023-00360-3 · Cited by 32
N6-Methyladenosine: A Novel RNA Imprint in Human Cancer
Yu, S., Li, X., Liu, S., Yang, R., Liu, X., & Wu, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01407 · Cited by 32
Mechanisms of epitranscriptomic gene regulation
Seo, K. W., & Kleiner, R. E. (2020) · Biopolymers · doi:10.1002/bip.23403 · Cited by 32
Li, Y., Bedi, R. K., Wiedmer, L., Sun, X., Danzhi Huang, A., & Caflisch, A. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.0c01136 · Cited by 32
Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis
Fang, F., Wang, X., Li, Z., Ni, K., & Xiong, C. (2021) · Molecular Human Reproduction · doi:10.1093/molehr/gaab025 · Cited by 32
Self-citationThe Role of N6-Methyladenosine Modified Circular RNA in Pathophysiological Processes
Tang, M., & Lv, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60131 · Cited by 32
Madugalle, S. U., Liau, W., Zhao, Q., Li, X., Gong, H., Marshall, P. R., Periyakaruppiah, A., Zajaczkowski, E. L., Leighton, L. J., Ren, H., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0943-23.2023 · Cited by 32
Self-citationmRNA nuclear export: how mRNA identity features distinguish functional RNAs from junk transcripts
Palazzo, A. F., Qiu, Y., & Kang, Y. M. (2023) · RNA Biology · doi:10.1080/15476286.2023.2293339 · Cited by 32
N6-methylation in the development, diagnosis, and treatment of gastric cancer
Wang, J., Zhao, G., Zhao, Y., Zhao, Z., Yang, S., Zhou, A., Li, P., & Zhang, S. (2024) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2023-0103 · Cited by 31
Reading m6A marks in mRNA: A potent mechanism of gene regulation in plants
Nguyen, T. K. H., & Kang, H. (2024) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13781 · Cited by 31
Tang, H., Zhang, R., & Zhang, A. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01570 · Cited by 31
The role of RNA N6-methyladenosine methyltransferase in cancers
Huang, J., Chen, Z., Chen, X., Chen, J., Cheng, Z., & Wang, Z. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.021 · Cited by 31
m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity
Rønningen, T., Dahl, M. B., Valderhaug, T. G., Çayır, A., Keller, M., Tönjes, A., Blüher, M., & Böttcher, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.778875 · Cited by 31
Glucose Regulates m6A Methylation of RNA in Pancreatic Islets
Bornaque, F., Delannoy, C. P., Courty, É., Rabhi, N., Carney, C., Rolland, L., Moreno, M., Gromada, X., Bourouh, C., Petit, P., et al. (2022) · Cells · doi:10.3390/cells11020291 · Cited by 31
Shan, M., Liu, D., Sun, L., Yang, M., He, M., Zhang, Y., Xiang, L., Lu, L., Chen, L., Niu, D., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2023.216598 · Cited by 31
Strength in Diversity: Nuclear Export of Viral RNAs
Gales, J. P., Kubina, J., Geldreich, A., & Dimitrova, M. (2020) · Viruses · doi:10.3390/v12091014 · Cited by 31
METTL3 as a master regulator of translation in cancer: mechanisms and implications
Esteva-Socias, M., & Aguiló, F. (2024) · NAR Cancer · doi:10.1093/narcan/zcae009 · Cited by 30
Liufu, C., Luo, L., Pang, T., Zheng, H., Yang, L., Lü, L., & Chang, S. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02574-w · Cited by 30
Role of N6‐methyladenosine RNA modification in cancer
Qu, Y., Gao, N., Zhang, S., Gao, L., He, B., Wang, C., Gong, C., Shi, Q., Li, Z., Yang, S., et al. (2024) · MedComm · doi:10.1002/mco2.715 · Cited by 30
m6A modification of RNA and its role in cancer, with a special focus on lung cancer
Khan, R. I. N., & Malla, W. A. (2021) · Genomics · doi:10.1016/j.ygeno.2021.06.013 · Cited by 30
LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2/LATS1
Mao, J., Qiu, H., & Guo, L. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.083 · Cited by 30
YTHDF3 modulates hematopoietic stem cells by recognizing RNA m6A modification on Ccnd1
Zhang, X., Cong, T., Wei, L., Zhong, B., Wang, X., Sun, J., Wang, S., Xu, M. M., Zhu, P., Jiang, H., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.279739 · Cited by 30
Self-citationHu, C., Liu, J., Li, Y., Jiang, W., Ji, D., Liu, W., & Ma, T. (2022) · Biomolecules · doi:10.3390/biom12081042 · Cited by 30
RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis
Ma, W., & Wu, T. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00214.2022 · Cited by 30
Khan, F. A., Nsengimana, B., Awan, U. A., Ji, X., Ji, S., & Dong, J. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00789-1 · Cited by 30
Emerging Roles of N6-Methyladenosine on HIV-1 RNA Metabolism and Viral Replication
Riquelme-Barrios, S., Pereira-Montecinos, C., Valiente‐Echeverría, F., & Soto‐Rifo, R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00576 · Cited by 30
Zhao, S., Liu, J., Wu, Q., & Zhou, X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1268646 · Cited by 29
SR proteins in cancer: function, regulation, and small inhibitor
Bei, M., & Xu, J. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00594-6 · Cited by 29
N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases
Tan, M., Liu, S., & Liu, L. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01736-5 · Cited by 29
Li, Z., Zhang, C., Huang, G., Zhang, Z., Wang, Q., Liu, X., Qin, Y., Zhou, H., Hou, A., He, J., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07500-8 · Cited by 29
Self-citationChen, S., Wang, Y., Zhang, J., Liu, B., Liu, W., Cao, G., Li, R., Li, H., Zhai, N., Song, X., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07608-x · Cited by 29
Ma, N., Song, P., Liu, Z., Li, Y., Cai, Z., Ding, M., Ma, X., Xu, Q., Yue, Y., Luo, T., et al. (2025) · Nature Plants · doi:10.1038/s41477-025-02013-w · Cited by 29
Deng, X., Wu, D., Zhao, Y., Qing, Y., Wu, H., & Chen, J. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.12.001 · Cited by 29
Mandal, S. D., & Ray, P. S. (2020) · Genomics · doi:10.1016/j.ygeno.2020.12.027 · Cited by 29
Decoding m6A mRNA methylation by reader proteins in cancer
Han, B., Wei, S., Li, F., Zhang, J., Li, Z., & Gao, X. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.047 · Cited by 29
The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies
Zhao, Y., & Peng, H. (2022) · Cancers · doi:10.3390/cancers14020332 · Cited by 29
Konan, S. N., Ségéral, E., Bejjani, F., Bendoumou, M., Said, M. A., Gallois‐Montbrun, S., & Emiliani, S. (2022) · Retrovirology · doi:10.1186/s12977-022-00589-1 · Cited by 29
Yang, M., Sun, M., & Zhang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.879848 · Cited by 29
The role and regulatory mechanism of m6A methylation in the nervous system
Jiang, L., Li, X., Wang, S., Yuan, Z., & Cheng, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.962774 · Cited by 29
Bian, Y., Li, J., Shen, H., Li, Y., Hou, Y., Huang, L., Song, G., & Qiao, C. (2022) · The FASEB Journal · doi:10.1096/fj.202200700rr · Cited by 29
Decoding m6A mRNA methylation by reader proteins in liver diseases
Sun, L., Chen, X., Zhu, S., Wang, J., Diao, S., Liu, J., Xu, J., Li, X., Sun, Y.-Y., Huang, C., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.054 · Cited by 29
Wang, J., Li, Y., & Zhang, S. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.08.042 · Cited by 28
Li, B., Zhou, Q., Cai, L., Li, L., Xie, C., Li, D., Zhu, F., Li, X., Zhao, X., Liu, X., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114597 · Cited by 28
Self-citationBu, F., Wang, H.-Y., Xu, C., Song, K.-L., Dai, Z., Wang, L.-T., Ying, J., & Chen, J. (2024) · Theranostics · doi:10.7150/thno.99019 · Cited by 28
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Shi, T., Zhang, H., & Chen, Y. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01368-z · Cited by 28
Maimaiti, A., Turhon, M., Cheng, X., Su, R., Kadeer, K., Axier, A., Ailaiti, D., Aili, Y., Abudusalamu, R., Ajimu, K., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.889141 · Cited by 28
Li, Y., Zhang, W., Dai, Y., & Chen, K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.986995 · Cited by 28
N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases
Luan, J., Kopp, J. B., & Zhou, H. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.10.009 · Cited by 28
Gao, X., Liang, X., Liu, B., Hong, Y., He, H., Shen, Y., Chen, J., Huang, X., Hu, B., Li, W., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202301292r · Cited by 28
Self-citationHuang, X., Zhang, J., Cun, Y., Ye, M., Ren, Z., Guo, W., Ma, X., Liu, J., Weiwei, L., Sun, X., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.02.016 · Cited by 27
Self-citationFan, D., Xia, Y., Lu, C. C., Ye, Q., Xi, X., Wang, Q., Wang, Z., Wang, C., & Xiao, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.627893 · Cited by 27
N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
Quan, C., Othmane, B., Hu, J., Li, H., Yu, A., Liu, P., Yi, Z., Qiu, D., Ren, W., Ma, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.697026 · Cited by 27
The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
Zhang, Z., Liu, F., Chen, W., Liao, Z., Zhang, B., Zhang, B., Chu, L., Chu, L., & Zhang, Z. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00281-2 · Cited by 27
Self-citationHistone H1 regulates non-coding RNA turnover on chromatin in a m6A-dependent manner
Fernández-Justel, J. M., Santa-María, C., Martín-Vírgala, S., Ramesh, S., Ferrera-Lagoa, A., Salinas‐Pena, M., Isoler‐Alcaráz, J., Maslon, M. M., Jordan, A., Cáceres, J. F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111329 · Cited by 27
The effects of RNA methylation on immune cells development and function
Zha, L., Wang, J., & Cheng, X. (2022) · The FASEB Journal · doi:10.1096/fj.202200716r · Cited by 27
The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K–Akt–mTOR signalling
Liu, J., Zuo, H., Wang, Z., Wang, W., Qian, X., Xie, Y.-Y., Peng, D., Xie, Y., Hong, L., You, W., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13410 · Cited by 27
Self-citationWang, X., Chen, Q., Bing, Z., Zhou, S., Xu, Z. C., Hou, Y., Zhao, Y., Zhao, S., & Wang, T. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.81595 · Cited by 27
Self-citationSong, M., Yao, H., Sun, Z., Chen, D., Xu, X., Long, G., Wu, L., & Hu, W. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00515-z · Cited by 27
Aufgebauer, C. J., Bland, K. M., & Horner, S. M. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2023.12.004 · Cited by 27
The m6A epitranscriptome opens a new charter in immune system logic
Ma, Z., Gao, X., Shuai, Y., Xing, X., & Ji, J. (2020) · Epigenetics · doi:10.1080/15592294.2020.1827722 · Cited by 27
Discovery of a new inhibitor for YTH domain-containing m 6 A RNA readers
Wang, C., & Zhou, H. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00105b · Cited by 26
A brief review of RNA modification related database resources
Ma, J., Zhang, L., Chen, S., & Liu, H. (2021) · Methods · doi:10.1016/j.ymeth.2021.03.003 · Cited by 26
Role of N6-Methyladenosine (m6A) Methylation Regulators in Hepatocellular Carcinoma
Qu, N., Bo, X., Li, B., Ma, L., Wang, F., Zheng, Q., Xiao, X., Huang, F., Shi, Y., & Zhang, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.755206 · Cited by 26
Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer
Mobet, Y., Liu, X., Liu, T., Yu, J., & Yi, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.813581 · Cited by 26
N6-methyladenosine (m6A) RNA modification in tumor immunity
Zheng, S., Han, H., & Lin, S. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0534 · Cited by 26
The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer
Luo, L., Zhen, Y., Peng, D., Wei, C., Zhang, X., Liu, X., Han, L., & Zhang, Z. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01113-2 · Cited by 26
Self-citationRegulatory role of RNA N6-methyladenosine modifications during skeletal muscle development
Yu, B., Liu, J., Zhang, J., Mu, T., Feng, X., Ma, R., & Gu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.929183 · Cited by 26
Zhang, M., Liu, J., Yu, C., Tang, S., Jiang, G., Zhang, J., Zhang, H., Xu, J., & Xu, W. (2022) · Antioxidants · doi:10.3390/antiox11122370 · Cited by 26
Cen, Y., Chen, L., Liu, Z., Lin, Q., Fang, X., Yao, H., & Gong, C. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01352-x · Cited by 26
Metadata
- Authors
- Roundtree, I. A., Luo, G.-Z., Zhang, Z., Wang, X., Zhou, T., Cui, Y., Sha, J., Huang, X., Guerrero, L., Xie, P., He, E., Shen, B., & He, C.
- Affiliations
- Howard Hughes Medical Institute (US)
- ShanghaiTech University (CN)
- State Key Laboratory of Reproductive Medicine (CN)
- University of Chicago (US)
- Corresponding author
- Shen, Bin
- He, Chuan
- ORCID
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2017-10-06
- Volume
- 6
- ISSN
- 2050-084X (ISSN-L)
- PMC
- PMC5648532
- OpenAlex
- W2764301500
- Cited by
- 1,256
- References
- 59
- Citations by year
- 2026: 99 · 2025: 163 · 2024: 199 · 2023: 198 · 2022: 201 · 2021: 181 · 2020: 114 · 2019: 57 · 2018: 43
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- eLife (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Chicago (cc-by)
- Funders
- National Institute of General Medical Sciences (F30GM117646, HG008688, GM113194)
- Howard Hughes Medical Institute
- National Science Foundation (CHE-1048528)
- National Natural Science Foundation of China (31171377, 31471400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- YTHDC1, N6-methyladenosine, m6A reader proteins, mRNA export, mRNA splicing, SRSF3, NXF1, mRNA modification, RNA metabolism
- MeSH terms
- Serine-Arginine Splicing Factors, RNA Splicing Factors, Adenosine, HeLa Cells, Humans, Nerve Tissue Proteins, Protein Binding, RNA, Messenger, RNA-Binding Proteins, Active Transport, Cell Nucleus, Nucleocytoplasmic Transport Proteins, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-13, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-13 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.